Breaking News

Biora BioJet Delivery Platform Meets Key Performance Milestones

BioJet device exceeded performance targets for delivery of collaborator AstraZeneca’s molecule in preclinical study.

Biora Therapeutics Inc., a biotech company focused on creating innovative smart pills designed for targeted drug delivery to the GI tract, and systemic, needle-free delivery of biotherapeutics, reported that its BioJet Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration with AstraZeneca. The BioJet platform is designed to use needle-free, liquid jet injection to deliver drug into the small intestine for systemic absorption. The BioJet platf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters